T21 allows patients to access certain qualifying medical cannabis products at a discounted price while collecting data to build up the real world evidence on the effects of Cannabis-Based Medicinal Products (CBMPs).

Drug Science will use the data from T21 to provide evidence for NHS funding of medical cannabis treatment.

Sign up below to receive monthly updates including our latest data findings.

* indicates required

Please select all the ways you would like to hear from Drug Science: